Biggest Blockbuster Drugs of All Time
Lipitor, Humira and Advair boosted the bottom lines of Big Pharma companies and their shareholders for years.
A prescription drug that surpasses $1 billion in sales is known as a blockbuster. It's a rare feat, but when a pharmaceutical company finds a true blockbuster drug the payoff is enormous. How enormous? Check out the three best-selling prescription drugs of all time.
Blockbuster Drug #1: Lipitor
Company: Pfizer (PFE)
Treats: High cholesterol
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Lifetime sales: $150.1 billion
Originally developed by Warner-Lambert, Lipitor was approved in the U.S. in 1997. Pfizer acquired its rival in 2000 to gain sole ownership of the cholesterol-fighting drug – and it was well worth it. At one point, Lipitor accounted for one-fourth of Pfizer’s sales. The patent expired in 2011.
Blockbuster Drug #2: Humira
Company: AbbVie (ABBV)
Treats: Ankylosing spondylitis, arthritis, Crohn’s disease, plaque psoriasis, ulcerative colitis
Lifetime sales: $109.2 billion
Doctors praise Humira’s ability to combat damaging inflammation caused by a number of diseases. Sales will likely peak in 2018 as the drug begins to lose patent protection, but it’s been a heck of a run. Humira is owned by AbbVie, an industry giant that was spun off from Abbott Labs in 2013.
Blockbuster Drug #3: Advair
Company: GlaxoSmithKline (GSK)
Treats: Chronic obstructive pulmonary disease, asthma
Lifetime sales: $95.7 billion
Advair has been a huge seller since its approval in 2001. And even though its U.S. patent expired in 2010, no successful generic competitor has surfaced. Copying the drug isn’t the problem. Rather, rivals have yet to figure out how to copy the inhaler. Until they do, Glaxo investors can breathe easy.
Get Kiplinger Today newsletter — free
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.
-
Why Uber Stock Is Volatile After GM's Cruise Announcement
Uber stock is swinging this week following news that General Motors is restructuring its Cruise unit. Here's what you need to know.
By Joey Solitro Published
-
UnitedHealth Stock Falls as Lawmakers Eye Insurers, PBMs
UnitedHealth stock is continuing to fall Thursday after the introduction of bipartisan legislation targeting PBMs and healthcare giants. Here's what to know.
By Joey Solitro Published
-
Best Stocks to Buy for Fed Rate Cuts
Consider these stock and fund picks now that the Federal Reserve's rate-cutting campaign is underway.
By Jeff Reeves Last updated
-
Stock Market Today: Nasdaq Jumps 451 Points After AMD Earnings, Fed Meeting
The main indexes notched impressive gains Wednesday on solid earnings and signs the Fed could start cutting rates as soon as September.
By Karee Venema Published
-
Why You Should Invest In Healthcare Stocks
It stands to reason that investing in healthcare is less volatile than investing in other sectors. After all, people get sick in both good times and bad.
By James K. Glassman Published
-
The 12 Best Bear Market ETFs to Buy Now
ETFs Investors who are fearful about the more uncertainty in the new year can find plenty of protection among these bear market ETFs.
By Kyle Woodley Published
-
How Big Should My Emergency Fund Be?
Brandon Copeland NFL linebacker and Kiplinger contributing editor Brandon Copeland discusses the importance of building an emergency fund.
By Brandon Copeland Published
-
Homeowners Insurance: How to Protect Your Home
Brandon Copeland NFL linebacker and Kiplinger contributing editor Brandon Copeland discusses the ins and outs of homeowners insurance.
By Brandon Copeland Published
-
The 10 Best Stocks for a Bear Market
stocks to buy The ideal bear-market stock pick should have a defensive business, a long history of dividend growth and relatively low volatility. Here are 10 stocks that fit that bill.
By Dan Burrows Published
-
15 Stocks Warren Buffett Is Buying (And 7 He's Selling)
stocks Berkshire Hathaway CEO Warren Buffett is a bull once more! The Oracle and his team entered eight new positions and added to others in a big way.
By Dan Burrows Published